Stock Analysis on Net
Stock Analysis on Net

GlaxoSmithKline PLC (NYSE:GSK)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 27, 2015.

Income Statement

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Paying users area

Try for free

GlaxoSmithKline PLC pages available for free this week:

The data is hidden behind: . Unhide it.

  • Get 1-month access to GlaxoSmithKline PLC for $22.49, or

  • get full access to the entire website for at least 3 months from $62.19.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

GlaxoSmithKline PLC, consolidated income statement

US$ in millions, translated from GBP £

Microsoft Excel
12 months ended: Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Turnover
Cost of sales
Gross profit
Selling, general and administration
Research and development
Royalty income
Impairment of equity investments
Disposal of equity investments
Disposal of businesses and assets
Gain on settlement of pre-existing collaborations on acquisition of HGS
Gain on acquisition of the Shionogi-ViiV Healthcare joint venture
Fair value remeasurements on contingent consideration recognised in business combinations
Fair value adjustments on derivative financial instruments
Other income (expense)
Other operating income
Operating profit
Interest income
Realised gains on liquid investments
Fair value adjustments on derivatives at fair value through profit or loss
Finance income
Interest expense
Fair value hedges
Fair value movements on other derivatives at fair value through profit or loss
Reclassification of cash flow hedge from other comprehensive income
Unwinding of discounts on provisions
Movements on amounts owed to non-controlling interests
Other finance expense
Finance costs
Profit on disposal of interest in associates
Share of after tax profits of associates and joint ventures
Profit before taxation
Taxation
Profit after taxation for the year
Profit attributable to non-controlling interests
Profit attributable to shareholders

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Income statement item Description The company
Turnover Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. GlaxoSmithKline PLC turnover increased from 2012 to 2013 but then decreased significantly from 2013 to 2014.
Operating profit The net result for the period of deducting operating expenses from operating revenues. GlaxoSmithKline PLC operating profit decreased from 2012 to 2013 and from 2013 to 2014.
Profit before taxation Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. GlaxoSmithKline PLC profit before taxation increased from 2012 to 2013 but then decreased significantly from 2013 to 2014.
Profit attributable to shareholders The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. GlaxoSmithKline PLC profit attributable to shareholders increased from 2012 to 2013 but then decreased significantly from 2013 to 2014.